United States · FDA National Drug Code directory
Nebivolol
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 31722-585_103af555-44dd-5dfb-e063-6294a90a259f
- Product NDC
- 31722-585
- Form
- TABLET
- Composition / generic term
- Nebivolol
- Labeler
- Camber Pharmaceuticals, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20210917
- Source listing expiry
- 20261231
Source-listed ingredients
- NEBIVOLOL HYDROCHLORIDE — 2.5 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET in 1 BOTTLE (31722-585-01) · 31722-585-01
- 30 TABLET in 1 BOTTLE (31722-585-30) · 31722-585-30
- 12 BLISTER PACK in 1 CARTON (31722-585-32) / 10 TABLET in 1 BLISTER PACK (31722-585-31) · 31722-585-32
- 15 BLISTER PACK in 1 CARTON (31722-585-34) / 10 TABLET in 1 BLISTER PACK (31722-585-33) · 31722-585-34
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →